Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win ...

Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...

MODERNA said on Friday it has filed a marketing application for the review of its updated Covid-19 vaccine with the US Food and Drug Administration (FDA).

Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...